Dopamine D-3 receptor polymorphism is not associated with the polycystic ovary syndrome

Objective: To determine if a polymorphism of the dopamine D-3 receptor gene (2 allele), which has been reported previously to be associated with polyc ystic ovary syndrome (PCOS) in a population of United States Hispanic women , is associated with the disorder in the southeastern United States. Design: Prospective case-control study. Setting: University reproductive endocrinology laboratory and outpatient cl inic. Patient(s): Consecutive patients of non-Hispanic white race diagnosed with PCOS (n = 152) and healthy controls (n = 96). Intervention(s): None. Main Outcome Measure(s): Patient and control dopamine D-3 receptor genotype s, with the 1 allele representing the wild type and the 2 allele denoting a highly prevalent polymorphism. Result(s): No difference was noted in the distribution of the three dopamin e D-3 receptor genotypes (i.e., 1:1, 1:2, and 2:2) among PCOS patients as c ompared with controls. Furthermore, in contrast to a previous report, the 2 :2 genotype was not more prevalent among PCOS patients than among controls. Conclusion(s): Our population of non-Hispanic white women from the southeas tern United States did not demonstrate an association between a dopamine D- 3 receptor polymorphism and PCOS. (Fertil Steril(R) 1999;71:436-8. (C)1999 by American Society for Reproductive Medicine.).